Table 2.
Comparison of BKPyV excretion rates among HIV-infected patients
| Category | Total | No. of BKPyV negatives | No. of BKPyV positives | P-value |
|---|---|---|---|---|
| Overall | 137 | 49 (35.8) | 88 (64.2) | |
| Gender, n (%) | 0.0391 | |||
| Male | 121 | 47 (38.8) | 74 (61.2) | |
| Female | 16 | 2 (12.5) | 14 (87.5) | |
| Age, years, n (%) | 0.0232 | |||
| ≤20 | 1 | 1 (100) | 0 (0.00) | |
| 21–40 | 88 | 34 (38.6) | 54 (61.4) | |
| 41–60 | 35 | 12 (34.3) | 23 (65.7) | |
| >60 | 13 | 2 (15.4) | 11 (84.6) | |
| CD4+ cells/mm, n (%) | 0.0891 | |||
| <200 | 55 | 15 (27.3) | 40 (72.7) | |
| ≥200 | 82 | 34 (41.5) | 48 (58.5) | |
| Treatment, n (%) | ||||
| Tenofovir | 61 | 21 (34.4) | 40 (65.6) | 0.7691 |
| Zidovudine | 43 | 20 (46.5) | 23 (53.5) | 0.0761 |
| Lamivudine | 111 | 42 (37.8) | 69 (62.2) | 0.2961 |
| Efavirenz | 88 | 35 (39.8) | 53 (60.2) | 0.1901 |
| Comorbidity, n (%) | ||||
| Hepatitis B | 8 | 3 (37.5) | 5 (62.5) | NS |
| TB | 21 | 3 (14.3) | 18 (85.7) | 0.0261 |
| Lymphoma | 6 | 2 (33.3) | 4 (66.6) | NS |
| Cryptococcal | 9 | 5 (55.6) | 4 (44.4) | NS |
| meningitis | ||||
| PCP | 6 | 3 (50.0) | 3 (50.0) | NS |
1. Pearson Chi-Square, Continuity Correction and Fisher’s exact test for categorical variables;
2. Independent samples t test for numerical data